The Breakthrough Alliance (“BTA”), a digital health research consortium, was created to accelerate a greater number of digital health innovations through the generation of exclusive, evidence-based research and insights. The BTA Research & Strategy Program (“Program”) provides research and testing to innovative technology companies worldwide as determined by the research consortium.

The Call for Applications to the Program seeks to identify health related or healthcare technology innovators that may be best suited to implement a pilot project under certain criteria as explained below and may be determined by the Program leadership including Sponsor and Administrator. Each pilot will be administered by HITLAB in a sample of appropriate target end users for a research study duration (sample size and duration shall be determined on a case-by-case basis to achieve valid, rapid verification efforts and at the sole discretion of BTA).

Specific Program goals include: 

• Enable health or healthcare technology companies to benefit from rigorous and cost-effective methods for generating meaningful, evidence-driven data that seek to validate their concept, prototypes, or products and attract key clients and investors.
• Expand the network of stakeholders granted access to digital health resources
• Accelerate the growth and development of health/healthcare Innovator solutions worldwide.